Law360@Law360

2 years ago

The Federal Circuit on Friday upheld a preliminary injunction barring NeoGenomics Laboratories Inc. from selling certain cancer tests while a North Carolina federal court decided whether they infringed Natera Inc. patents. https://t.co/kJgFYiOrL3

Natera v Neogenomics 7/15 #FedCir affirms https://t.co/gHFBsEDaMC’s “quite ably,” “carefully crafted” preliminary injunction halting sales of Neo’s likely infringing tumor-informed MRD test RaDaR to detect cancer relapse. Patient access concerns/public interest properly weighed.

Economic Times@EconomicTimes

2 years ago

Supreme Court upholds NPPA's Rs 4.65 cr recovery from Sun Pharma for drug price violation https://t.co/6Lc1rk4587